✦ LIBER ✦

Anti-idiotype colorectal cancer vaccine 105AD7 immunogenic

Book ID: 120870047
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2000
Weight: 121 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200012350-00013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-idiotype vaccines tackle colorectal

Anti-idiotype vaccines tackle colorectal cancer

✍ Angus Dalgleish 📂 Article 📅 1996 🏛 The Lancet 🌐 English ⚖ 284 KB

Immune responses to the 105AD7 human ant

Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma

✍ Pritchard-Jones, K; Spendlove, I; Wilton, C; Whelan, J; Weeden, S; Lewis, I; Hal 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

T-cell responses in osteosarcoma patient

T-cell responses in osteosarcoma patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55

✍ G.J. Ullenhag; I. Spendlove; N.F.S. Watson; C. Kallmeyer; K. Pritchard-Jones; L. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 644 KB

Anti-idiotype antibody vaccine therapy f

Anti-idiotype antibody vaccine therapy for cancer

✍ Bhattacharya-Chatterjee, Malaya; Chatterjee, Sunil K; Foon, Kenneth A 📂 Article 📅 2002 🏛 Informa plc 🌐 English ⚖ 262 KB

Randomized double-blind phase II surviva

Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer

✍ Maxwell-Armstrong, C A; Durrant, L G; Buckley, T J D; Scholefield, J H; Robins, 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

105Ad7 cancer vaccine stimulates anti-tu

105Ad7 cancer vaccine stimulates anti-tumour helper and cytotoxic T-cell responses in colorectal cancer patients but repeated immunisations are required to maintain these responses

✍ Lindy G. Durrant; Declan J. Buckley; R. Adrian Robins; Ian Spendlove 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 99 KB

105AD7 is a human anti-idiotypic antibody that recognises the binding site of the anti-tumour antibody 791T/36 and can thereby mimic the CD55 antigen. The molecular basis of 105AD7 mimicry has been identified with 3 CDR regions of 105AD7 showing similarity to 3 regions of CD55. These regions have be